Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic RhinosinusitisGlobeNewsWire • 05/06/24
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 04/30/24
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 04/30/24
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 04/26/24
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/28/24
Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 03/25/24
Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?Zacks Investment Research • 03/22/24
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/21/24
Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep goingZacks Investment Research • 03/08/24
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 03/01/24
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?Zacks Investment Research • 02/26/24
What Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'Zacks Investment Research • 01/17/24
5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New YearZacks Investment Research • 12/11/23
Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/07/23
Lyra Therapeutics Announces Appointment of Ronan O'Brien as Chief Legal OfficerGlobeNewsWire • 10/16/23
Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus SurgeryGlobeNewsWire • 09/12/23
Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic RhinosinusitisGlobeNewsWire • 08/29/23